These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 3103410)

  • 1. Flecainide acetate for conversion of acute supraventricular tachycardia to sinus rhythm.
    Crozier IG; Ikram H; Kenealy M; Levy L
    Am J Cardiol; 1987 Mar; 59(6):607-9. PubMed ID: 3103410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous flecainide acetate for supraventricular tachycardias.
    Hellestrand KJ
    Am J Cardiol; 1988 Aug; 62(6):16D-22D. PubMed ID: 3136630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of long-term oral flecainide acetate in patients with responsive supraventricular tachycardia.
    Hellestrand KJ
    Am J Cardiol; 1996 Jan; 77(3):83A-88A. PubMed ID: 8607396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of recurrent supraventricular tachyarrhythmias with flecainide or a flecainide and amiodarone combination].
    Purcaro A; Capestro F; Ciampani N; Fratadocchi GB; Mazzanti M; Costantini C; Molini E
    G Ital Cardiol; 1987 Aug; 17(8):690-8. PubMed ID: 3121426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and utility of flecainide acetate in the routine care of patients with supraventricular tachyarrhythmias: results of a multicenter trial. The Flecainide Supraventricular Tachycardia Study Group.
    Hopson JR; Buxton AE; Rinkenberger RL; Nademanee K; Heilman JM; Kienzle MG
    Am J Cardiol; 1996 Jan; 77(3):72A-82A. PubMed ID: 8607395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Summary of efficacy and safety of flecainide for supraventricular arrhythmias.
    Anderson JL; Jolivette DM; Fredell PA
    Am J Cardiol; 1988 Aug; 62(6):62D-66D. PubMed ID: 3136638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of intravenous flecainide acetate in patients with concealed atrioventricular pathway with supraventricular tachycardia].
    Song Y
    Zhonghua Xin Xue Guan Bing Za Zhi; 1991 Dec; 19(6):361-3, 397. PubMed ID: 1821351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous flecainide acetate for the clinical management of paroxysmal tachycardias.
    Nathan AW; Camm AJ; Bexton RS; Hellestrand KJ
    Clin Cardiol; 1987 May; 10(5):317-22. PubMed ID: 3109795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short- and long-term efficacy and safety of flecainide acetate for supraventricular arrhythmias.
    Hohnloser SH; Zabel M
    Am J Cardiol; 1992 Aug; 70(5):3A-9A; discussion 9A-10A. PubMed ID: 1387287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of the anti-arrhythmia effect of intravenous flecainide in supraventricular tachyarrhythmias].
    Garre L; Alvarez A; Cianciulli T; Quiroga J; Califano J; Mautner B
    Arch Inst Cardiol Mex; 1989; 59(3):241-4. PubMed ID: 2506843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of refractory supraventricular arrhythmias with flecainide acetate.
    Till JA; Rowland E; Shinebourne EA; Ward DE
    Arch Dis Child; 1987 Mar; 62(3):247-52. PubMed ID: 3105471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flecainide acetate in the treatment of supraventricular tachycardias: value of programmed electrical stimulation for long-term prognosis.
    van Wijk LM; Crijns HJ; van Gilst WH; Wesseling H; Lie KI
    Am Heart J; 1989 Feb; 117(2):365-9. PubMed ID: 2492738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrophysiologic and clinical effects of flecainide for recurrent paroxysmal supraventricular tachycardia.
    Hoff PI; Tronstad A; Oie B; Ohm OJ
    Am J Cardiol; 1988 Sep; 62(9):585-9. PubMed ID: 3137798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conversion of supraventricular arrhythmias to sinus rhythm using flecainide.
    Goy JJ; Grbic M; Hurni M; Finci L; Maendly R; Duc J; Sigwart U
    Eur Heart J; 1985 Jun; 6(6):518-24. PubMed ID: 4043101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrophysiologic effects and clinical efficacy of flecainide in children with recurrent paroxysmal supraventricular tachycardia.
    Musto B; D'Onofrio A; Cavallaro C; Musto A; Greco R
    Am J Cardiol; 1988 Aug; 62(4):229-33. PubMed ID: 3135739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of paroxysmal reentrant supraventricular tachycardia with flecainide acetate.
    Kim SS; Lal R; Ruffy R
    Am J Cardiol; 1986 Jul; 58(1):80-5. PubMed ID: 3728336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Catheter ablation in supraventricular tachycardia].
    Pitschner HF; Neuzner J
    Z Kardiol; 1996; 85 Suppl 6():45-60. PubMed ID: 9064982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flecainide acetate treatment of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation: dose-response studies. The Flecainide Supraventricular Tachycardia Study Group.
    Pritchett EL; DaTorre SD; Platt ML; McCarville SE; Hougham AJ
    J Am Coll Cardiol; 1991 Feb; 17(2):297-303. PubMed ID: 1899432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of class IC antiarrhythmic agents for the treatment of coexisting supraventricular and ventricular tachycardia.
    Rinkenberger RL; Naccarelli GV; Berns E; Dougherty AH
    Am J Cardiol; 1988 Aug; 62(6):44D-55D. PubMed ID: 3136636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flecainide for supraventricular tachycardia in children.
    Zeigler V; Gillette PC; Hammill B; Ross BA; Ewing L
    Am J Cardiol; 1988 Aug; 62(6):41D-43D. PubMed ID: 3136635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.